Disclosures for "Real World Use of a CSF Circulating Tumor Cell Assay in the Diagnosis and Management of Leptomeningeal Metastasis"
-
Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
-
Dr. Haberli has nothing to disclose.